Authors:
Naito, A
Ohtake, Y
Hasegawa, H
Fukaya, Y
Kurasawa, T
Naito, K
Matsukawa, H
Oguma, T
Ezure, Y
Tsuriya, Y
Tanaka, H
Koike, K
Shigenobu, K
Citation: A. Naito et al., Pharmacological profile of VP-343, a novel selective vasopressin V-2 receptor antagonist, in rats, BIOL PHAR B, 23(2), 2000, pp. 182-189
Authors:
Naito, A
Hasegawa, H
Kurasawa, T
Ohtake, Y
Matsukawa, H
Ezure, Y
Tsuriya, Y
Koike, K
Shigenobu, K
Citation: A. Naito et al., The therapeutic efficacy of VP-343, a selective vasopressin V-2 receptor antagonist, in the experimental SIADH rat model, BIOL PHAR B, 23(11), 2000, pp. 1323-1327
Authors:
Ohtake, Y
Naito, A
Hasegawa, H
Kawano, K
Morizono, D
Taniguchi, M
Tanaka, Y
Matsukawa, H
Naito, K
Oguma, T
Ezure, Y
Tsuriya, Y
Citation: Y. Ohtake et al., Novel vasopressin V2 receptor-selective antagonists, pyrrolo[2,1-a]quinoxaline and pyrrolo[2,1-c][1,4]benzodiazepine derivatives, BIO MED CH, 7(6), 1999, pp. 1247-1254
Citation: T. Kawasumi et al., Improvement of peroxyl radical scavenging bioassay based on bactericidal action of tert-butyl peroxyl radical, BIOS BIOT B, 63(3), 1999, pp. 577-580
Citation: T. Kawasumi et al., Antioxidant activity of a medicine based on Aspergillus oryzae NK Koji measured by a modified t-butyl peroxyl radical scavenging assay, BIOS BIOT B, 63(3), 1999, pp. 581-584